Clinical Trial Update: Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing OROS hydromorphone HCl sustained-release tablets with immediate-release hydromorphone tablets for chronic pain has completed, evaluati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Hydromorphone HCl Immediate-Release tablets (hydromorphone hydrochloride immediate-release)
• OROS Hydromorphone HCl SR tablets (hydromorphone hydrochloride sustained-release)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Pain | Phase 3 | Status: COMPLETED